Lyra Therapeutics, Inc. (LYRA) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 2 Buy, 3 Hold.
The consensus price target is $0.50, representing an upside of 13.6% from the current price $0.44.
LYRA Stock — 12-Month Price Forecast
$0.50
▲ +13.61% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Lyra Therapeutics, Inc., the price target is $0.50.
The average price target represents a +13.61% change from the last price of $0.44.
LYRA Analyst Ratings
Hold
Based on 5 analysts giving stock ratings to Lyra Therapeutics, Inc. in the past 3 months
